Phreesia raises $11.6M to make waiting-room clipboards obsolete

Phreesia raises $11.6M to make waiting-room clipboards obsolete

Phreesia, maker of electronic tablets to replace those pesky intake clipboards at doctors’ offices, announced today that it brought in $11.6 million in a round led by BlueCross BlueShield Venture Partners and Sandbox Industries. This brings the New York company’s total capital raised to $25 million — which it plans to use to enlist more doctors to use the product in the U.S. According to Phreesia, thousands already do.

It also says it should be greatly… Continue Reading

Extreme Reach grabs $1.5M for video advertising

Extreme Reach, a company that integrates advertisements into digital videos across web, television and mobile platforms, just brought in $1.5 million in first-round funding to build its sales and marketing operations.

Based in Needham, Mass., the firm effectively holds clients’ hands through the process from the point of ad creation through performance tracking. It says that many companies have shied away from investing in digital video ads because they aren’t familiar enough with the process. Extreme… Continue Reading

Qteros readies for near-term cellulosic ethanol production

Qteros readies for near-term cellulosic ethanol production

A technology that might offer some respite to first-generation ethanol makers like Verasun and Pacific Ethanol has received a significant $25 million from backers including oil giant BP and George Soros’s investment fund. The company in question is Qteros, formerly called SunEthanol, a little-known startup placing big bets on a plucky microbe.

Qteros is one of a large group of companies trying to engineer a microorganism to cheaply break down woody matter, including everything from corn… Continue Reading

Life sciences briefing: Monday, Sept. 17, 2007

Life sciences briefing: Monday, Sept. 17, 2007

Featured companies: Bioptigen, Echo Therapeutics, Forest Laboratories, Intrinsic Therapeutics, Microbia, Phreesia, Sontra Medical, TransMedics, Xanthus Pharmaceuticals

[NOTE: This is a catchup briefing, posted on 9/28/07. I've adjusted the item's timestamp to keep the briefings in chronological order. --D.P.H.]

Patient-info digitizer Phreesia takes in $10.3M — Phreesia, a New York company that claims to offer a “100% free” — but ad-sponsored — digital patient check-in application to doctors, raised $10.3 million in a second funding round. Investors included Polaris Ventures… Continue Reading

Pogo Jet files to go public, despite having no revenue

Pogo Jet, a Chicopee, Mass., provider of a private jet charter service, filed to go public and raise $103.5 million.

Remarkably, the company wants to do so despite having no revenue. It won’t even launch its service until 2009, and is still awaiting government approval. Its surprising that it wants the public market to fund its launch.

Here’s the SEC filing.

The IPO will be conducted through an “OpenIPO” process, which allows buyers bid for the shares in… Continue Reading

SunEthanol, latest cellulosic ethanol company, raises round

SunEthanol, an Amherst, Mass. biofuels technology company, said it has raised a first round of funding to commercialize the so-called “Q Microbe,” a natural bacteria that helps convert cellulose into ethanol.

VeraSun Energy, Battery Ventures and Long River Ventures, led the investment, the amount of which is undisclosed.

There are at least a dozen companies working on ways to produce cellulosic ethanol, which is cleaner way to make ethanol. The process relies on waste from… Continue Reading